Efficacy and Safety of AJU-S56 5% in Dry Eye Syndrome Patients

Phase 3 Unknown 396 enrolled AJU Pharm Co., Ltd. GL Pharm Tech Corporation · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is planned to Evaluate the Efficacy and Safety of test drug (AJU-S56 5%) compared to control drug(vehicle) in Patients with Dry Eye Disease.

Timeline

Start: 2023-11-10
Primary completion: 2024-05
Completion: 2024-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	AJU-S56	Unknown	5 %	—

Efficacy and Safety of AJU-S56 5% in Dry Eye Syndrome Patients

Summary

Timeline

Drugs

Indications